Abingworth as of March 31, 2015
Portfolio Holdings for Abingworth
Abingworth holds 17 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sientra Common | 17.9 | $42M | 2.2M | 19.12 | |
| Paratek Common | 17.0 | $40M | 1.3M | 30.78 | |
| Supernus Common (SUPN) | 11.8 | $28M | 2.3M | 12.08 | |
| Dicerna Common | 9.9 | $23M | 973k | 24.01 | |
| Proteon Common | 9.6 | $23M | 2.0M | 11.23 | |
| Amarin Spons ADR (AMRN) | 8.0 | $19M | 8.1M | 2.34 | |
| Cempra Common | 7.6 | $18M | 524k | 34.31 | |
| Lombard Medical Common (EVARF) | 5.6 | $13M | 3.5M | 3.80 | |
| Portola Common | 5.6 | $13M | 347k | 37.96 | |
| Regulus Common | 2.4 | $5.5M | 327k | 16.93 | |
| Zogenix Common | 1.4 | $3.2M | 2.3M | 1.37 | |
| Hyperion Common | 1.2 | $2.9M | 63k | 45.89 | |
| Anthera Common | 0.8 | $2.0M | 438k | 4.47 | |
| Oncogenex Pharma Common | 0.5 | $1.3M | 604k | 2.11 | |
| ChemoCentryx Common | 0.4 | $824k | 110k | 7.51 | |
| Flex Pharma Common | 0.1 | $200k | 10k | 20.00 | |
| Epirus Biopharma Common | 0.0 | $70k | 7.9k | 8.87 |
